Condition
Statins, HMG-CoA
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Unknown1
Withdrawn1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT00965185Not ApplicableCompleted
Statin Therapy to Improve Atherosclerosis in HIV Patients
NCT02790528Phase 4Withdrawn
Statin Therapy In Patients With Vasospastic Angina
NCT00509574UnknownPrimary
Association of Genetic Polymorphisms With Lipid Lowering Effects of Statin Therapy
Showing all 3 trials